Company Overview

■ Medicine Man Technologies, Inc. ("Medicine Man Technologies" or the "Company") provides an established platform to facilitate the acquisition of companies under the leadership of CEO Justin Dye and his seasoned team ■ ■ ■ EXECUTIVE SUMMARY Medicine Man Technologies, Inc. (OTC Ticker: "MDCL”) is aggregating a premier portfolio of Colorado cannabis companies, positioning MDCL as one of the largest vertically-integrated operators in the state and a platform to lead consolidation and growth of cannabis in the U.S. Overview Since 2014 and headquartered in Denver, CO, the Company has historically provided consulting services, nutrients and supplies Upon legislation allowing outside investors into Colorado, the Company instituted a plant touching strategy backed by Dye Capital Justin Dye, former Albertsons Companies executive and Cerberus Capital operating executive, leads a best-in-class management team bringing Fortune 500 backgrounds and M&A / integration expertise The management team is primed to buy, integrate and synergize the portfolio of assets with a deep bench of cannabis entrepreneurs During the past year, the Company has entered into agreements to acquire 11 companies, which when closed will result in a scalable, vertically integrated Colorado operator All of the targets have a proven track record and are well positioned in their respective markets By establishing optimized operating procedures across the platform, the Company expects to extract significant benefits The retail strategy will implement product mix optimization, increased foot traffic technologies, targeted loyalty marketing and other sophisticated operating strategies For FYE 2019, the Company estimates pro forma revenue and EBITDA margins of $144MM (¹) and ~20%-30%, respectively 34 Dispensaries 64K Retail Sq. Ft. $3MM Avg. Revenue by Dispensary(2) Vertically Integrated Operations From Seed to Sale By the Numbers 13 Cultivation Sites 2.1MM Cultivation Sq. Ft. 100,000 Lbs / Year Note: These figures are unaudited and represent the Company's current estimates. These figures are subject to adjustment and change upon completion of the audits for each of the entities included therein (1) Revenue after elimination of $26MM of intercompany payments. PCAOB / Quality of Earnings audits currently underway, anticipated for completion April 2020 (2) Avg. revenue by dispensary based on FYE 2019 retail revenue / total expected retail stores post Colorado Rollup MEDICINE MAN 5 Manufacturing Facilities 23K Manufacturing Sq. Ft. >100 Products MEDICINE MAN TECHNOLOGIES OPEN 1 Consulting Practice 22 States with Strong Relationships 9 Success Nutrients™ Product Lines

View entire presentation